More on COLL

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-17.3% Growth)
- Ratings (6.4 Score)
- Holders
- FDA Archive

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Collegium Pharma (NQ:COLL)
Delayed: 24.00 -0.61 (2.48%)
Prev. Close $24.61  
Open$24.85 
52 Wk High$30.58 
52 Wk Low$8.24 
Day High$25.46 
Day Low$23.93 
P/E N/A  
EPS$0.00 
Volume1,407,000 

Friends, Peers and Foes (?): GUD (more...)

Aug 24, 2026 05:03 PM Form SCHEDULE 13G COLLEGIUM PHARMACEUTICAL Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Aug 20, 2026 03:00 PM Barclays flags an "attractive entry point" in this pharma stock
Aug 19, 2026 03:21 AM Collegium Pharmaceutical (COLL) PT Lowered to $48 at Barclays
Aug 14, 2026 05:29 PM Form SCHEDULE 13G COLLEGIUM PHARMACEUTICAL Filed by: FULLER & THALER ASSET MANAGEMENT, INC.
Aug 13, 2026 03:57 PM Collegium Pharma (COLL) 2700 contracts of August 39 calls trade
Aug 13, 2026 07:31 AM Form 8-K COLLEGIUM PHARMACEUTICAL For: Aug 12
Aug 13, 2026 07:30 AM Collegium Pharmaceutical launches $50M accelerated share repurchase
Aug 13, 2026 07:30 AM Collegium Announces $50 Million Accelerated Share Repurchase Program
Aug 7, 2026 07:48 AM Collegium Pharmaceutical (COLL) PT Lowered to $43 at Piper Sandler
Aug 6, 2026 08:17 AM Collegium Pharma (COLL) Tops Q2 EPS by 20c; Offers Guidance
View All Articles

Entities mentioned with COLL

View All Entities